[1]
Shetty, S., Bhoraskar, A., Mohan, J.C., Chafekar, D., Tripathi, K., Sivalingam, M., Desai, B., Gude, D., Sridhar, G., Varghese, C., Shah, V.T. and Dargad, R. 2019. Selective Imidazoline Receptor Agonists: redefining the role of centrally acting agents in management of hypertension. International Journal of Advances in Medicine. 6, 5 (Sep. 2019), 1688–1694. DOI:https://doi.org/10.18203/2349-3933.ijam20194234.